Cancer registry software market CAGR to rise 12.75% until 2028

Thanks to the increasing prevalence of the disease and the adoption of EHRs.

The global cancer registry software market is anticipated to grow by $97.1m until 2028 at an estimated compound annual growth rate (CAGR) of 12.75%.

A report by Technavio revealed that the market is experiencing notable growth amidst the rising prevalence of cancer and the adoption of electronic health records (EHR).

“The software solutions enable seamless data integration and interoperability, allowing medical professionals to access evidence-based medicine and make informed decisions for cancer treatment,” the report said.

Moreover, its use is attributed to the changing landscape of healthcare costs, population health management, information exchange, and disease registries.

However, security concerns remain a challenge hindering the market’s further growth, with evolving technologies and increasing cyberattacks in healthcare posing as significant risks.

“To address these challenges, it is crucial to adhere to established guidelines, invest in secure technology tools, and ensure proper network connectivity,” the report added.